Abstract
We establish a triple-stacking capillary electrophoresis (CE) separation method to monitor methotrexate (MTX) and its eight metabolites in cerebrospinal fluid (CSF). Three stacking methods with different mechanisms were combined and incorporated into CE separation. Complete stacking and sharp peaks were achieved. Firstly, the optimized buffer (60 mM phosphate containing 15% THF and 100 mM SDS) was filled into the capillary, which was followed by the higher conductivity buffer (100 mM phosphate, 2 psi for 45 s). The analytes extracted from CSF were injected at 2 psi for 99.9 s, which provided long sample zones and pH junction for focusing. Finally, the stacking step was performed by sweeping, and separation was achieved by micellar electrokinetic chromatography. The results of the linear regression equations indicated high linearity (r ≥ 0.9981) over the range of 0.5–7 μM. In intra- and inter-batch results, all data of RSD and RE were below 11%, indicating good precision and accuracy of this method. The LODs (S/N = 3) were 0.1 μM for MTX, 7-hydroxymethotrexate (7-OHMTX) and MTX-polyglutamates (MTX-(Glu)n, n = 2–5), 0.2 μM for MTX-(Glu)6, and 0.3 μM for 2,4-diamino-N 10-methylpteroic acid (DAMPA) and MTX-(Glu)7. Our method was implemented for analysis of MTX and its metabolites in the CSF, and could be used for evaluation of its curative effects of acute lymphoblastic leukemia patients. The data were also confirmed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. The results showed good coincidence.
Similar content being viewed by others
References
Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chamner BA (1983) N Engl J Med 309:1094–1104
Wan H, Holmen AG, Wang Y, Lindberg W, Englund M, Nagard MB, Thompson RA (2003) Rapid Commun Mass Spectrom 17:2639–2648
Thompson PA, Murry DJ, Rosner GL, Lunagomez S, Blaney SM, Berg SL et al (2007) Cancer Chemother Pharmacol 59:847–853
Cole PD, Alcaraz MJ, Smith AK, Tan J, Kamen BA (2006) Cancer Chemother Pharmacol 57:826–834
Sczesny F, Hempel G, Boos J, Blaschke G (1998) J Chromatogr B 718:177–185
Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP (2000) Immunopharmacology 47:247–257
Widemann BC, Sung E, Anderson L, Salzer WL, Balis FM, Monitjo KS et al (2000) J Pharmacol Exp Ther 294:894–901
Ranganathan P, McLeod HL (2006) Arthritis Rheum 54:1366–1377
Angelis-Stoforidis P, Vajda FJ, Christophidis N (1999) Clin Exp Rheumatol 17:313–320
Gool SWV, Meyer GD, Voorde AVd, Vanmechelen E, Vanderstichele H (2004) Neurotoxicology 25:471–480
Jonsson P, Hoglund P, Wiebe T, Schroder H, Seidel H, Skarby T (2007) Anticancer Drugs 18:941–948
Hiraga S, Arita N, Ohnishi T, Kohmura E, Yamamoto K, Oku Y et al (1999) J Neurosurg 91:221–230
Milano G, Thyss A, Serre Debeauvais F, Laureys G, Benoit Y, Deville A et al (1990) Eur J Cancer 26:492–495
Seidel H, Andersen A, Kvaloy JT, Nygaard R, Moe PJ, Jacobsen G et al (2000) Leuk Res 24:193–199
Balis FM, Blaney SM, McCully CL, Bacher JD, Murphy RF, Poplack DG (2000) Cancer Chemother Pharmacol 45:259–264
Li H, Luo W, Zeng Q, Lin Z, Luo H, Zhang Y (2007) J Chromatogr B 845:164–168
Anzai T, Jaffe N, Wang YM (1987) J Chromatogr 415:445–449
Albertioni F, Pettersson B, Beck O, Rask C, Seideman P, Peterson C (1995) J Chromatogr B 665:163–170
Dervieux T, Orentas Lein D, Marcelletti J, Pischel K, Smith K, Walsh M, Richerson R (2003) Clin Chem 49:1632–1641
Kuo CY, Wu HL, Kou HS, Chiou SS, Wu DC, Wu SM (2003) J Chromatogr A 1014:93–101
Kuo CY, Chiou SS, Wu SM (2006) Electrophoresis 27:2905–2909
Suzuki Y, Arakawa H, Maeda M (2003) Anal Sci 19:111–115
Horakova J, Petr J, Maier V, Znaleziona J, Stanova A, Marak J et al (2007) J Chromatogr A 1155:193–198
Britz-McKibbin P, Markuszewski MJ, Iyanagi T, Matsuda K, Nishioka T, Terabe S (2003) Anal Biochem 313:89–96
Horakova J, Petr J, Maier V, Tesarova E, Veis L, Armstrong DW et al (2007) Electrophoresis 28:1540–1547
Albert M, Debusschere L, Demesmay C, Rocca JL (1997) J Chromatogr A 757:291–296
Zhang H, Zhou L, Chen X (2008) Electrophoresis 29:1556–1564
Lin CH, Kaneta T (2004) Electrophoresis 25:4058–4073
Chien RL, Burgi DS (1992) Anal Chem 84:1046–1050
Burgi DS (1993) Anal Chem 65:3726–3729
Britz-McKibbin P, Terabe S (2003) J Chromatogr A 1000:917–934
Britz-McKibbin P, Chen DDY (2000) Anal Chem 72:1242–1252
Quirino JP, Terabe S (1999) Anal Chem 71:1638–1644
Quirino JP, Terabe S (1998) Science 282:465–468
Britz-McKibbin P, Otsuka K, Terabe S (2002) Anal Chem 74:3736–3743
Britz-McKibbin P, Terabe S (2002) Chem Rec 2:397–404
Shih CM, Lin CH (2005) Electrophoresis 26:3495–3499
Cheng HL, Liao YM, Chiou SS, Wu SM (2008) Electrophoresis 29:3665–3673
Howard GM, Schwende FJ (1997) J Chromatogr B 693:431–436
Quirino JP, Terabe S (2000) Anal Chem 72:1023–1030
Acknowledgments
We gratefully acknowledge the support of the National Science Council of Taiwan and Kaohsiung Medical University in funding this work. We also express our gratitude to the Center of Excellence for Environmental Medicine (KMU-EM-98-1-2) for partial financial support provided for this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheng, HL., Chiou, SS., Liao, YM. et al. Analysis of methotrexate and its eight metabolites in cerebrospinal fluid by solid-phase extraction and triple-stacking capillary electrophoresis. Anal Bioanal Chem 398, 2183–2190 (2010). https://doi.org/10.1007/s00216-010-4152-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-4152-3